Tenet Healthcare Corp’s recent filing unveils that its CEO Sutaria Saumya unloaded Company’s shares for reported $15.03 million on Sep 10 ’25. In the deal valued at $190.78 per share,78,762 shares were sold. As a result of this transaction, Sutaria Saumya now holds 368,683 shares worth roughly $68.85 million.
Then, Sutaria Saumya bought 78,762 shares, generating $15,025,892 in total proceeds.
Before that, Lynch Christopher S. sold 8 shares. Tenet Healthcare Corp shares valued at $1,468 were divested by the Director at a price of $183.44 per share. As a result of the transaction, Lynch Christopher S. now holds 12,350 shares, worth roughly $2.31 million.
Wolfe Research downgraded its Tenet Healthcare Corp [THC] rating to a Peer perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who increased its forecast for the stock in late May from “an Equal weight” to “an Overweight”. Robert W. Baird also remained covering THC and has decreased its forecast on April 15, 2025 with a “Neutral” recommendation from previously “an Outperform” rating. Morgan Stanley started covering the stock on March 26, 2025. It rated THC as “an Overweight”.
Price Performance Review of THC
On Monday, Tenet Healthcare Corp [NYSE:THC] saw its stock fall -3.15% to $186.75. Over the last five days, the stock has lost -2.97%. Tenet Healthcare Corp shares have risen nearly 18.45% since the year began. Nevertheless, the stocks have risen 47.94% over the past one year.
How much short interest is there in Tenet Healthcare Corp?
A steep rise in short interest was recorded in Tenet Healthcare Corp stocks on 2025-08-29, dropping by -0.75 million shares to a total of 2.34 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 3.09 million shares. There was a decline of -32.05%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 26, 2025 when TD Cowen began covering the stock and recommended ‘”a Buy”‘ rating along with a $175 price target.
